Trials / Completed
CompletedNCT01832870
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer
Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Prostate Oncology Specialists, Inc. · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sipuleucel-T | |
| DRUG | ipilimumab |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2013-04-16
- Last updated
- 2017-08-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01832870. Inclusion in this directory is not an endorsement.